News
Seven pharmaceutical companies join academic researchers to speed TB drug discovery
Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, have launched a ground breaking partnership that aims to speed the discovery of essential new treatments for tuberculosis. The...
News
Study finds drug warning labels need overhaul
Many patients seem to ignore prescription drug warning labels with instructions that are critical for safe and effective use, according to a study by a Kansas State University researcher working with scientists at Michigan State University. ...
News
A better way to test new treatments?
A new approach to testing medical treatment options could ensure that more patients get the most beneficial treatment for them - but still yield valuable research results that stand up to scientific scrutiny. The...
News
Researchers block pathway to cancer cell replication
Research suggests that patients with leukemia sometimes relapse because standard chemotherapy fails to kill the self-renewing leukemia initiating cells, often referred to as cancer stem cells. In such cancers, the cells lie dormant for a...
News
Bristol-Myers Squibb and AstraZeneca expand diabetes alliance
Bristol-Myers Squibb Company and Amylin Pharmaceuticals, Inc. announced that Bristol-Myers Squibb will acquire Amylin for $31.00 per share in cash, pursuant to a cash tender offer and second step merger, or an aggregate purchase price of approximately $5.3...
News
FDA grants priority review to the new drug application for Bayer’s Regorafenib
Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib for the treatment of patients with...
News
New compound holds promise for treating Duchenne MD
Scientists at UCLA have identified a new compound that could treat certain types of genetic disorders in muscles. It is a big first step in what they hope will lead to human clinical trials for Duchenne muscular dystrophy....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read